Abstract:Anticancer activities of platinum (II) complexes are modulated by the chelated phosphine ligands, with more azadiphosphines resulting in more cytotoxicity. This work reports the preparations and anticancer activities of a set of platinum (II) complexes. Two types of bidentate ligands, azadiphosphine (PNP) and diphosphine (PP), were applied to afford different kinds of platinum centers, the homoleptic complexes, [Pt (PNP)2]2+ (1 and 2) and [Pt (PP)2]2+ (4), and the hybrid complex, [Pt (PNP)(PP)]2+ (3). All these complexes are characterized by various analytical techniques, and their structures were validated using single‐crystal X‐ray diffraction analysis. Notably, the stability of the complexes 1–4 is differentiated both in phosphate‐buffered saline (PBS) and in the culture media (RPMI‐1640), relative to the type of coordinated diphosphine ligands, specifically, the more PNP ligands, the less stability. The bite angles of P‐Pt‐P bonds in 1–4 would be reliant on their stability, so that complexes 1 and 2 with small bite angles tend to be labile. A mechanistic understanding on the decomposition of 2 is proposed with the aid of mass analysis. As a result, their anticancer activities should be also associated with their stability so that the chelated ligands, with more PNP ligands, lead to more cytotoxicity. Mechanistically, the poisonous platinum (II) derivatives of complex 2 should interact with the nucleus DNA, whereas the intact complex 4 is not traceable, confirming from a γ‐H2AX‐related immunofluorescence staining kit. Additionally, complex 2 exhibits severe toxicity toward several cancer cells as well as a normal cell. Furthermore, complex 2 has inhibited the formation and viability of three‐dimensional T24 mammospheres, reminding it of a promising candidate for anticancer treatments. Overall, the present work provides a way for the systematic investigation to elucidate how a bidentate diphosphine ligand modulates the stability and the anticancer activities of the corresponding square‐planner platinum (II) complex.

Structural Evidence For The Facile Chelate-Ring Opening Reactions Of Novel Platinum(Ii)-Pyridine Carboxamide Complexes

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

THE SYNTHESIS AND CHARACTERIZATION OF DINUCLEAR PLATINUM COMPLEXES BRIDGED BY DIPYRIDYL SELENIDES OR SULFIDES

Antitumor Active Monofunctional Platinum(ii) Complexes: Synthesis, Structural Characterization and Reactivity Towards Biomolecules

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Synthesis, crystal structures and anticancer activity of pt(II) complexes with two sterically hindered 2-methylpyridine groups as the carrier

Toward the Design of Novel Polynuclear Platinum Antitumor Complexes: a Polydentate Ligand System Based on Dipyridylamine and 1,3,5-Trimethylenebenzene.

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Synthesis and Structure of Platinum(ii) Complexes Containing an Asymmetric Chelating Diamine 2-Morpholinoethylamine As the Carrier

Synthesis, Characterization and Biological Evaluation of Platinum(II) Complexes with a Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivative

Binuclear Monofunctional Platinum(ii) Complexes Formed by Hexaazamacrocyclic Bisdien Ligands: Crystal Structure, DNA Binding and Cytotoxicity Studies

Design, Synthesis and in Vitro Cytotoxicity of Novel Dinuclear Platinum(Ii) Complexes

Design, Synthesis, and Biological Features of Platinum(Ii) Complexes with Rigid Steric Hindrance

Modulating the Anticancer Activity of Square‐Planar Platinum (II) Complex by Its Chelated Diphosphine

Synthesis, Characterization, and Antitumor Biological Evaluation of Novel Fluorine‐containing Platinum (IV) Complexes

Synthesis and Biological Evaluation of Mixed Ammine/amine Platinum(ii) Complexes with Dicarboxylate Containing Organic Nitrate As Ligand

Synthesis and anticancer activities of novel Pt (II) and Pd (II) complexes with 4‐(2,2′:6′,2′′‐terpyridin‐4′‐yl)phenol as ligand

Synthesis, Cytotoxicity, and Apoptosis Induction Study of Antitumor Dinuclear Platinum(ii) Complexes.